Your browser doesn't support javascript.
loading
Precise DNA cleavage using CRISPR-SpRYgests.
Christie, Kathleen A; Guo, Jimmy A; Silverstein, Rachel A; Doll, Roman M; Mabuchi, Megumu; Stutzman, Hannah E; Lin, Jiecong; Ma, Linyuan; Walton, Russell T; Pinello, Luca; Robb, G Brett; Kleinstiver, Benjamin P.
Afiliação
  • Christie KA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Guo JA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Silverstein RA; Department of Pathology, Harvard Medical School, Boston, MA, USA.
  • Doll RM; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Mabuchi M; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Stutzman HE; Biological and Biomedical Sciences Program, Harvard University, Boston, MA, USA.
  • Lin J; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Ma L; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Walton RT; Biological and Biomedical Sciences Program, Harvard University, Boston, MA, USA.
  • Pinello L; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Robb GB; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Kleinstiver BP; Molecular Biosciences/Cancer Biology Program, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nat Biotechnol ; 41(3): 409-416, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36203014
ABSTRACT
Methods for in vitro DNA cleavage and molecular cloning remain unable to precisely cleave DNA directly adjacent to bases of interest. Restriction enzymes (REs) must bind specific motifs, whereas wild-type CRISPR-Cas9 or CRISPR-Cas12 nucleases require protospacer adjacent motifs (PAMs). Here we explore the utility of our previously reported near-PAMless SpCas9 variant, named SpRY, to serve as a universal DNA cleavage tool for various cloning applications. By performing SpRY DNA digests (SpRYgests) using more than 130 guide RNAs (gRNAs) sampling a wide diversity of PAMs, we discovered that SpRY is PAMless in vitro and can cleave DNA at practically any sequence, including sites refractory to cleavage with wild-type SpCas9. We illustrate the versatility and effectiveness of SpRYgests to improve the precision of several cloning workflows, including those not possible with REs or canonical CRISPR nucleases. We also optimize a rapid and simple one-pot gRNA synthesis protocol to streamline SpRYgest implementation. Together, SpRYgests can improve various DNA engineering applications that benefit from precise DNA breaks.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clivagem do DNA / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clivagem do DNA / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2023 Tipo de documento: Article